CareLit Fachartikel

Phase III study of canakinumab (ACZ885) as adjuvant therapy in patients with surgically resected NSCLC

M Thomas, P Christopoulos, EB Garon, A Ardizzoni, F Barlesi, BC Cho, P De Marchi, Y Goto, S Lu, L Paz-Ares, DR Spigel, A Kay, P Cazorla Arratia, J Baum, YY Lau, C Zheng, JCH Yang · Pneumologie · 2019 · Heft S 01 S 01

Dokument
1194885
CareLit-ID
Jahr
2019
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
M Thomas, P Christopoulos, EB Garon, A Ardizzoni, F Barlesi, BC Cho, P De Marchi, Y Goto, S Lu, L Paz-Ares, DR Spigel, A Kay, P Cazorla Arratia, J Baum, YY Lau, C Zheng, JCH Yang
Ausgabe
Heft S 01 S 01 / 2019
Jahrgang 73
Seiten
–
Erschienen: 2019-03-01 00:00:00
ISSN
0934-8387
DOI
10.1055/s-0039-1678200

Zusammenfassung

Phase III study of canakinumab (ACZ885) as adjuvant therapy in patients with surgically resected NSCLC

Schlagworte

Phase Study Canakinumab Acz885 Adjuvant Therapy Patients Surgically Resected Nsclc Pneumologie